The short answer
L-5-HTP can cause drowsiness, and lofexidine can add to the effects of sedating products. Review the combination before use. The degree of added sedation has not been measured for this exact pair.
What this answer covers
Oral L-5-hydroxytryptophan, not L-tryptophan or an assumed equivalent whole-seed extract.
- Supplement or preparation
- L-5-HTP
- Medication ingredient
- lofexidine
Why drowsiness is the concern
Health Canada’s L-5-HTP monograph warns of possible drowsiness. Lofexidine can potentiate other sedating products, so existing sleepiness and other medicines matter.
What the warning does not establish
The sources do not quantify the extra sedation with lofexidine. The separate serotonin warnings attached to L-5-HTP do not show that this particular combination causes serotonin syndrome.
Check the exact ingredient and timing plan
Bring the L-5-HTP amount and full ingredient list to the treating team. L-tryptophan is a different supplement. No interval has been shown to eliminate possible combined drowsiness.
Protect alertness during withdrawal treatment
Do not drive or use machinery if drowsy, and follow the treatment team’s advice until you know how lofexidine affects you. Tell the team about alcohol and all sleep products. Contact them if sedation becomes troublesome; lofexidine should not be abruptly stopped without a plan.
Evidence and practical considerations
Side effects & toxicity
A conditional combined-drowsiness precaution is supported by exact supplement guidance and lofexidine labeling.
- Exact scope
- Oral L-5-hydroxytryptophan, not L-tryptophan or an assumed equivalent whole-seed extract. with Oral lofexidine for adult opioid withdrawal; label section 11 supports hydrochloride-to-active-moiety identity.
- Medication form and route
- oral supplement unless clinician-directed electrolyte correction requires another route
- Timing or duration
- Lofexidine course is symptom-guided up to 14 days; longer supplement studies do not establish acute co-use safety.
What remains uncertain
- No exact-pair clinical trial. This is an alertness assessment, not evidence of a serotonergic lofexidine interaction.
Factors that may matter: exact preparation; blood pressure and pulse; kidney function; other medicines; baseline electrolyte status or alertness.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Adults receiving treatment for opioid withdrawal symptoms.
Can cause hypotension, bradycardia, syncope and sedation. Avoid medicines lowering pulse or pressure; potentiates benzodiazepine CNS depression and is expected to potentiate other sedating drugs. Correct hypokalemia/hypomagnesemia first and monitor ECG at initiation in those patients because lofexidine prolongs QT. Abrupt discontinuation can raise blood pressure.
How this applies: RxNorm 28863 IN maps to this SPL; section 11 confirms salt-to-active-moiety identity. Applies to prescribed oral lofexidine for adult opioid withdrawal, not another alpha-2 agonist.
Does not establish supplement depletion, automatic supplementation, exact botanical interaction rates or a safe supplement spacing interval.
Source 2: official product guidance
webprod.hc-sc.gc.ca · Source check Sep 10, 2026
Population: Adults using oral L-5-hydroxytryptophan products.
Warns that drowsiness can occur and recommends caution with driving or machinery.
How this applies: Supports a conditional drowsiness precaution based on exact L-5-HTP identity.
No lofexidine study. Separate serotonergic warnings do not establish that lofexidine is serotonergic or that this pair causes serotonin syndrome.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Inspected sources applied to exact current available claim; no clinical review asserted. | |
| Research summary published |
Article revision: 9f139440c603a536
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.